Louis ND, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimling A (2016) WHO classification of tumors of the central nervous system, revised 4th edition. International Agency for Research on Cancer (IARC), Lyon
Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for "diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV". Acta Neuropathol 136(5):805–810. https://doi.org/10.1007/s00401-018-1913-0
Article
CAS
PubMed
PubMed Central
Google Scholar
Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F, Koelsche C, Wefers A, Reinhardt A, Huang K, Sievers P, Shimizu H, Nanjo H, Kobayashi Y, Miyake Y, Suzuki T, Adachi J-I, Mishima K, Sasaki A, Nishikawa R, Bewerunge-Hudler M, Ryzhova M, Absalyamova O, Golanov A, Sinn P, Platten M, Jungk C, Winkler F, Wick A, Hänggi D et al (2018) Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Acta Neuropathol 136(1):153–166. https://doi.org/10.1007/s00401-018-1849-4
Article
CAS
PubMed
Google Scholar
Domingues PH, Sousa P, Otero Á, Gonçalves JM, Ruiz L, de Oliveira C, Lopes MC, Orfao A, Tabernero MD (2014) Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype. Neuro Oncol 16(5):735–747. https://doi.org/10.1093/neuonc/not325
Article
PubMed
PubMed Central
Google Scholar
Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H, Perry A, Sahm F, Sloan A, von Deimling A, Wen PY, Aldape K, Zadeh G (2019) Molecular and translational advances in meningiomas. Neuro Oncology 21(Suppl 1):i4–i17. https://doi.org/10.1093/neuonc/noy178
Article
CAS
PubMed
PubMed Central
Google Scholar
Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D, Sturm D, Wirsching H-G, Berghoff AS, Baumgarten P, Kratz A, Huang K, Wefers AK, Hovestadt V, Sill M, Ellis HP, Kurian KM, Okuducu AF, Jungk C, Drueschler K, Schick M, Bewerunge-Hudler M, Mawrin C, Seiz-Rosenhagen M, Ketter R, Simon M et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18(5):682–694. https://doi.org/10.1016/S1470-2045(17)30155-9
Article
CAS
PubMed
Google Scholar
Reuss DE, Piro RM, Jones DTW, Simon M, Ketter R, Kool M, Becker A, Sahm F, Pusch S, Meyer J, Hagenlocher C, Schweizer L, Capper D, Kickingereder P, Mucha J, Koelsche C, Jäger N, Santarius T, Tarpey PS, Stephens PJ, Andrew Futreal P, Wellenreuther R, Kraus J, Lenartz D, Herold-Mende C, Hartmann C, Mawrin C, Giese N, Eils R, Collins VP et al (2013) Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol 125(3):351–358. https://doi.org/10.1007/s00401-013-1093-x
Article
CAS
PubMed
Google Scholar
Taylor MD, Northcott PA, Korshunov A, Remke M, Cho Y-J, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123(4):465–472. https://doi.org/10.1007/s00401-011-0922-z
Article
CAS
PubMed
Google Scholar
Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter SL, Cibulskis K, Erlich RL, Greulich H, Lawrence MS, Lennon NJ, McKenna A, Meldrim J, Ramos AH, Ross MG, Russ C, Shefler E, Sivachenko A, Sogoloff B, Stojanov P, Tamayo P, Mesirov JP, Amani V, Teider N, Sengupta S, Francois JP, Northcott PA, Taylor MD et al (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488(7409):106–110. https://doi.org/10.1038/nature11329
Article
CAS
PubMed
PubMed Central
Google Scholar
Pietsch T, Haberler C (2016) Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline. Clin Neuropathol 35(6):344–352. https://doi.org/10.5414/NP300999
Article
PubMed
PubMed Central
Google Scholar
Sturm D, Witt H, Hovestadt V, Khuong-Quang D-A, Jones DTW, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, Kool M, Zapatka M, Becker N, Zucknick M, Hielscher T, Liu X-Y, Fontebasso AM, Ryzhova M, Albrecht S, Jacob K, Wolter M, Ebinger M, Schuhmann MU, van Meter T, Frühwald MC, Hauch H, Pekrun A, Radlwimmer B, Niehues T, von Komorowski G et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425–437. https://doi.org/10.1016/j.ccr.2012.08.024
Article
CAS
PubMed
Google Scholar
Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz H-J, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, Waszak SM, Erkek S, Jones DTW, Worst BC, Kool M, Zapatka M, Jäger N, Chavez L, Hutter B, Bieg M, Paramasivam N, Heinold M, Gu Z, Ishaque N, Jäger-Schmidt C et al (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547(7663):311–317. https://doi.org/10.1038/nature22973
Article
CAS
PubMed
PubMed Central
Google Scholar
Sahm F, Schrimpf D, Jones DTW, Meyer J, Kratz A, Reuss D, Capper D, Koelsche C, Korshunov A, Wiestler B, Buchhalter I, Milde T, Selt F, Sturm D, Kool M, Hummel M, Bewerunge-Hudler M, Mawrin C, Schüller U, Jungk C, Wick A, Witt O, Platten M, Herold-Mende C, Unterberg A, Pfister SM, Wick W, von Deimling A (2016) Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathol 131(6):903–910. https://doi.org/10.1007/s00401-015-1519-8
Article
CAS
PubMed
Google Scholar
Griffith M, Spies NC, Krysiak K, McMichael JF, Coffman AC, Danos AM, Ainscough BJ, Ramirez CA, Rieke DT, Kujan L, Barnell EK, Wagner AH, Skidmore ZL, Wollam A, Liu CJ, Jones MR, Bilski RL, Lesurf R, Feng Y-Y, Shah NM, Bonakdar M, Trani L, Matlock M, Ramu A, Campbell KM, Spies GC, Graubert AP, Gangavarapu K, Eldred JM, Larson DE et al (2017) CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer. Nat Genet 49(2):170–174. https://doi.org/10.1038/ng.3774
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang J, Baran J, Cros A, Guberman JM, Haider S, Hsu J, Liang Y, Rivkin E, Wang J, Whitty B, Wong-Erasmus M, Yao L, Kasprzyk A (2011) International Cancer genome consortium data portal--a one-stop shop for cancer genomics data. Database (Oxford) 2011:bar026. https://doi.org/10.1093/database/bar026
Article
CAS
Google Scholar
Illumina, Inc. (2014) bcl2fastq Conversion Software v1.8.4 User Guide. https://emea.support.illumina.com/content/dam/illuminasupport/documents/documentation/software_documentation/bcl2fastq/bcl2fastq_letterbooklet_15038058brpmi.pdf
Martin M (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 17(1):10. https://doi.org/10.14806/ej.17.1.200
Article
Google Scholar
Andrews S (2010) FASTQC. A quality control tool for high throughput sequence data. BibSonomy. https://www.bibsonomy.org/bibtex/f230a919c34360709aa298734d63dca3#export
Google Scholar
Li, H (2013) Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. ArXiv:1303.3997. https://arxiv.org/abs/1303.3997
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R (2009) The sequence alignment/map format and SAMtools. Bioinformatics 25(16):2078–2079. https://doi.org/10.1093/bioinformatics/btp352
Article
CAS
PubMed
PubMed Central
Google Scholar
Agilent Genomics NextGen Toolkit: LocatIt. Agilent. https://www.agilent.com/en/product/next-generation-sequencing/hybridization-based-next-generation-sequencing-ngs/ngs-software/agent-232879. Accessed 21 Oct 2014
Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK (2012) VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22(3):568–576. https://doi.org/10.1101/gr.129684.111
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38(16):e164. https://doi.org/10.1093/nar/gkq603
Article
CAS
PubMed
PubMed Central
Google Scholar
Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP (2011) Integrative genomics viewer. Nature Biotechnology 29:24–26. https://doi.org/10.1038/nbt.1754
Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BA, Piver MS (2000) Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. J Natl Cancer Inst 92(13):1088–1091. https://doi.org/10.1093/jnci/92.13.1088
Article
CAS
PubMed
Google Scholar
Seshan EV, Olshen BA (2010) DNAcopy: A Package for Analyzing DNA Copy Data. Bioconductor. https://bioconductor.org/packages/release/bioc/html/DNAcopy.html
Gu Z, Eils R, Schlesner M (2016) Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32(18):2847–2849. https://doi.org/10.1093/bioinformatics/btw313
Article
CAS
PubMed
Google Scholar
Dietmaier W, Lorenz J, Riemenschneider MJ (2015) Molekulare Diagnostik in der Neuropathologie. Pathologe 36(2):171–180. https://doi.org/10.1007/s00292-015-0002-6
Article
CAS
PubMed
Google Scholar
Nonoguchi N, Ohta T, Oh J-E, Kim Y-H, Kleihues P, Ohgaki H (2013) TERT promoter mutations in primary and secondary glioblastomas. Acta Neuropathol 126(6):931–937. https://doi.org/10.1007/s00401-013-1163-0
Article
CAS
PubMed
Google Scholar
Bieńkowski M, Piaskowski S, Stoczyńska-Fidelus E, Szybka M, Banaszczyk M, Witusik-Perkowska M, Jesień-Lewandowicz E, Jaskólski DJ, Radomiak-Załuska A, Jesionek-Kupnicka D, Sikorska B, Papierz W, Rieske P, Liberski PP (2013) Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients. PLoS One 8(6):e65444. https://doi.org/10.1371/journal.pone.0065444
Article
CAS
PubMed
PubMed Central
Google Scholar
Sciacchitano S, Lavra L, Ulivieri A, Magi F, de Francesco GP, Bellotti C, Salehi LB, Trovato M, Drago C, Bartolazzi A (2017) Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology. Oncotarget 8(30):49421–49442. https://doi.org/10.18632/oncotarget.17220
Article
PubMed
PubMed Central
Google Scholar
ILAC inspection committee (2019) Guidance on measurements performed as part of an inspection process. https://ilac.org/?ddownload=122667
DAkks Deutsche Akkreditierungsstelle (2012) Checkliste zur DIN EN ISO/IEC 17020:2012 für die Molekularpathologie. https://www.dakks.de/content/checkliste-zur-din-en-isoiec-170202012-für-die-molekularpathologie
Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121(3):397–405. https://doi.org/10.1007/s00401-011-0802-6
Article
CAS
PubMed
Google Scholar
Razis E, Kotoula V, Koliou G-A, Papadopoulou K, Vrettou E, Giannoulatou E, Tikas I, Labropoulos SV, Rigakos G, Papaemmanoyil S, Romanidou O, Bourkoula E, Nomikos P, Iliadis G, Nasioulas G, Selviaridis P, Polyzoidis K, Fountzilas G (2019) Is there an independent role of TERT and NF1 in high grade Gliomas? Transl Oncol 13(2):346–354. https://doi.org/10.1016/j.tranon.2019.10.016
Article
PubMed
PubMed Central
Google Scholar
Appin CL, Brat DJ (2014) Molecular genetics of gliomas. Cancer J 20(1):66–72. https://doi.org/10.1097/PPO.0000000000000020
Article
CAS
PubMed
Google Scholar
Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjöld M, Collins VP (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6(2):180–184. https://doi.org/10.1038/ng0294-180
Article
CAS
PubMed
Google Scholar
Remke M, Ramaswamy V, Peacock J, Shih DJH, Koelsche C, Northcott PA, Hill N, Cavalli FMG, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, Luu B, Jones DTW, Garzia L, Dubuc AM, Zhukova N, Vanner R, Kros JM, French PJ, van Meir EG, Vibhakar R, Zitterbart K, Chan JA, Bognár L, Klekner A, Lach B et al (2013) TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol 126(6):917–929. https://doi.org/10.1007/s00401-013-1198-2
Article
CAS
PubMed
PubMed Central
Google Scholar
Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho B-K, Kim S-K, Wang K-C, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng H-K, Eberhart CG et al (2017) Intertumoral heterogeneity within Medulloblastoma Subgroups. Cancer Cell 31(6):737–754.e6. https://doi.org/10.1016/j.ccell.2017.05.005
Article
CAS
PubMed
PubMed Central
Google Scholar
Wen PY, Norden AD, Drappatz J, Quant E (2010) Response assessment challenges in clinical trials of gliomas. Curr Oncol Rep 12(1):68–75. https://doi.org/10.1007/s11912-009-0078-3
Article
PubMed
Google Scholar
Nikiforova MN, Wald AI, Melan MA, Roy S, Zhong S, Hamilton RL, Lieberman FS, Drappatz J, Amankulor NM, Pollack IF, Nikiforov YE, Horbinski C (2016) Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors. Neuro Oncology 18(3):379–387. https://doi.org/10.1093/neuonc/nov289
Article
CAS
PubMed
Google Scholar
McNulty SN, Cottrell CE, Vigh-Conrad KA, Carter JH, Heusel JW, Ansstas G, Dahiya S (2019) Beyond sequence variation: assessment of copy number variation in adult glioblastoma through targeted tumor somatic profiling. Hum Pathol 86:170–181. https://doi.org/10.1016/j.humpath.2018.12.004
Article
CAS
PubMed
Google Scholar
Carter JH, McNulty SN, Cimino PJ, Cottrell CE, Heusel JW, Vigh-Conrad KA, Duncavage EJ (2017) Targeted next-generation sequencing in molecular subtyping of lower-grade diffuse Gliomas: application of the World Health Organization's 2016 revised criteria for central nervous system tumors. J Mol Diagn 19(2):328–337. https://doi.org/10.1016/j.jmoldx.2016.10.010
Article
CAS
PubMed
Google Scholar
Synhaeve NE, van den Bent MJ, French PJ, Dinjens WNM, Atmodimedjo PN, Kros JM, Verdijk R, Dirven CMF, Dubbink HJ (2018) Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics. Acta Neuropathol Commun:6. https://doi.org/10.1186/s40478-018-0633-y
Zacher A, Kaulich K, Stepanow S, Wolter M, Köhrer K, Felsberg J, Malzkorn B, Reifenberger G (2017) Molecular diagnostics of Gliomas using next generation sequencing of a Glioma-tailored gene panel. Brain Pathol 27(2):146–159. https://doi.org/10.1111/bpa.12367
Article
CAS
PubMed
Google Scholar
Ji MS, Eldred BSC, Liu R, Pianka ST, Molaie D, Kevan B, Pan S, Lai TJ, Nguyen NT, Chow FE, Yong WH, Cox CD, Reeh DN, Li T, Liau LM, Nghiemphu PL, Cloughesy TF, Li G, Lai A (2020) Targeted next-generation sequencing of 565 neuro-oncology patients at UCLA: a single-institution experience. Neurooncol Adv 2(1):vdaa009. https://doi.org/10.1093/noajnl/vdaa009
Article
PubMed
PubMed Central
Google Scholar
Jones DTW, Kocialkowski S, Liu L, Pearson DM, Bäcklund LM, Ichimura K, Collins VP (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68(21):8673–8677. https://doi.org/10.1158/0008-5472.CAN-08-2097
Article
CAS
PubMed
PubMed Central
Google Scholar
Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dalton JD, Li Y, Lee R, Tatevossian RG, Phoenix TN, Thiruvenkatam R, White E, Tang B, Orisme W, Gupta K, Rusch M, Chen X, Li Y, Nagahawhatte P, Hedlund E, Finkelstein D, Wu G, Shurtleff S, Easton J, Boggs K, Yergeau D, Vadodaria B, Mulder HL, Becksfort J, Becksford J, Gupta P et al (2014) C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature 506(7489):451–455. https://doi.org/10.1038/nature13109
Article
CAS
PubMed
PubMed Central
Google Scholar
Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, Reimand J, Mackay A, Carvalho DM, Remke M, Phillips JJ, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero F et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164(5):1060–1072. https://doi.org/10.1016/j.cell.2016.01.015
Article
CAS
PubMed
PubMed Central
Google Scholar
Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A, Liu EM, Reichel J, Porrati P, Pellegatta S, Qiu K, Gao Z, Ceccarelli M, Riccardi R, Brat DJ, Guha A, Aldape K, Golfinos JG, Zagzag D, Mikkelsen T, Finocchiaro G, Lasorella A, Rabadan R, Iavarone A (2012) Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 337(6099):1231–1235. https://doi.org/10.1126/science.1220834
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu G, Diaz AK, Paugh BS, Rankin SL, Ju B, Li Y, Zhu X, Qu C, Chen X, Zhang J, Easton J, Edmonson M, Ma X, Lu C, Nagahawatte P, Hedlund E, Rusch M, Pounds S, Lin T, Onar-Thomas A, Huether R, Kriwacki R, Parker M, Gupta P, Becksfort J, Wei L, Mulder HL, Boggs K, Vadodaria B, Yergeau D et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46(5):444–450. https://doi.org/10.1038/ng.2938
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, Orisme W, Punchihewa C, Parker M, Qaddoumi I, Boop FA, Lu C, Kandoth C, Ding L, Lee R, Huether R, Chen X, Hedlund E, Nagahawatte P, Rusch M, Boggs K, Cheng J, Becksfort J, Ma J, Song G, Li Y, Wei L, Wang J, Shurtleff S, Easton J et al (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45(6):602–612. https://doi.org/10.1038/ng.2611
Article
CAS
PubMed
PubMed Central
Google Scholar